why choose us

First received: August 02, 2023

Clinical Trial: A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Wilms Tumor

Study Type: INTERVENTIONAL


Official Title: A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors

Brief Summary: The purpose of this study is to find out whether selinexor is an effective treatment for people under the age of 51 who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, or another solid tumor that makes a higher than normal amount of XPO1 or has genetic changes that increase the activity of XP01.

Read more